On April 28, 2025, credit rating agency ICRA reaffirmed Indraprastha Medical Corporation Limited’s (IMCL) long-term rating at ‘[ICRA] AA’ with a ‘stable’ outlook and its short-term rating at ‘[ICRA] A1+’. This decision reflects IMCL’s strong presence in the National Capital Region (NCR), diversified revenue streams across specialties like oncology, neurology, cardiology, and nephrology, as well as its robust financial profile characterized by minimal gearing and strong liquidity. Business & Finance News
ICRA also considered IMCL’s association with Apollo Hospitals Enterprise Limited (AHEL), which holds a 25% stake in the company, providing significant operational, financial, and managerial support. However, the ratings are tempered by IMCL’s geographical concentration in two NCR hospitals and exposure to regulatory risks and competitive pressures in the healthcare sector.
Source (full link):
https://www.business-standard.com/markets/capital-market-news/icra-reaffirms-ratings-of-indraprastha-medical-corp-maintains-stable-outlook-125042800560_1.html
Disclaimer: This article is not authored or drafted by any employee of FinMen Advisors. The information presented is entirely sourced from the above news link. FinMen Advisors is not responsible for the accuracy, completeness, or reliability of the information.
